H.R.1660 - Global Health Innovation Act of 2017115th Congress (2017-2018) |
|Sponsor:||Rep. Sires, Albio [D-NJ-8] (Introduced 03/21/2017)|
|Committees:||House - Foreign Affairs | Senate - Foreign Relations|
|Latest Action:||Senate - 03/22/2018 Placed on Senate Legislative Calendar under General Orders. Calendar No. 364. (All Actions)|
|Roll Call Votes:||There has been 1 roll call vote|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.1660 — 115th Congress (2017-2018)All Information (Except Text)
Reported to Senate without amendment (03/22/2018)
Global Health Innovation Act of 2017
(Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.
Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.